Citrinin Provoke DNA Damage and Cell-Cycle Arrest Related to Chk2 and FANCD2 Checkpoint Proteins in Hepatocellular and Adenocarcinoma Cell Lines.


Journal

Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765

Informations de publication

Date de publication:
17 Jul 2024
Historique:
received: 06 06 2024
revised: 11 07 2024
accepted: 15 07 2024
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 26 7 2024
Statut: epublish

Résumé

Citrinin (CIT), a polyketide mycotoxin produced by

Identifiants

pubmed: 39057961
pii: toxins16070321
doi: 10.3390/toxins16070321
pii:
doi:

Substances chimiques

Checkpoint Kinase 2 EC 2.7.1.11
Fanconi Anemia Complementation Group D2 Protein 0
CHEK2 protein, human EC 2.7.11.1
Citrinin 3S697X6SNZ
FANCD2 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : This research was funded by strengthening the scientific research and innovation capacities of the Faculty of Pharmacy and Biochemistry, University of Zagreb (FarmInova)financed by the European Regional Development Fund, Operational Program Competitivenes
ID : KK.01.1.1.02.0021
Organisme : University of Zagreb
ID : support for 2022

Auteurs

Darija Stupin Polančec (D)

OnkoLab Ltd., 10000 Zagreb, Croatia.

Sonja Homar (S)

University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Biochemistry and Molecular Biology, 10000 Zagreb, Croatia.

Daniela Jakšić (D)

University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Microbiology, 10000 Zagreb, Croatia.

Nevenka Kopjar (N)

Mutagenesis Unit, Institute for Medical Research and Occupational Health, 10000 Zagreb, Croatia.

Maja Šegvić Klarić (M)

University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Microbiology, 10000 Zagreb, Croatia.

Sanja Dabelić (S)

University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Biochemistry and Molecular Biology, 10000 Zagreb, Croatia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH